Carcinoma and atypical hyperplasia in reduction mammaplasty: Increased sampling leads to increased detection. a prospective study

Plastic and Reconstructive Surgery

Volumn 124, Issue 5, 2009, Pages 1386-1392

  Ambaye, Abiy B ^a   MacLennan, Susan E ^a   Goodwin, Andrew J ^a   Suppan, Thomas ^a   Naud, Shelly ^a   Weaver, Donald L ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; BREAST; BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; HYPERPLASIA; INCIDENCE; INCIDENTAL FINDINGS; MAMMAPLASTY; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 73549100663     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181b988da     Document Type: Article

References (32)

1. American Society of Plastic Surgeons. National Procedural Statistics. 2007. Available at: http://www.plasticsurgery.org/ Documents/Media/statistics/ 2007-full-statistics-report.pdf.
2. Kakagia D, Fragia K, Grekou A, Tsoutsos D. Reduction mammaplasty specimens and occult breast carcinomas. Eur J Surg Oncol. 2005;31:19-21.
3. Ishag MT, Bashinsky DY, Beliaeva IV, Niemann TH, Marsh WL Jr. Pathologic findings in reduction mammaplasty specimens. Am J Clin Pathol. 2003;120:377-380.
4. Petit JY, Rietjens M, Contesso G, Bertin F, Gilles R. Contralateral mastoplasty for breast reconstruction: A good opportunity for glandular exploration and occult carcinomas diagnosis. Ann Surg Oncol. 1997;4:511-515.
5. Colwell AS, Kukreja J, Breuing KH, Lester S, Orgill DP. Occult breast carcinoma in reduction mammaplasty specimens: 14-year experience. Plast Reconstr Surg. 2004;113:1984-1988.
6. Jansen DA, Murphy M, Kind GM, Sands K. Breast cancer in reduction mammaplasty: Case reports and a survey of plastic surgeons. Plast Reconstr Surg. 1998;101:361-364.
7. Cook IS, Fuller CE. Does histopathological examination of breast reduction specimens affect patient management and clinical follow-up? Clin Pathol. 2004;57:286-289.
8. Ayhan S, Basterzi Y, Yavuzer R, et al. Histologic profiles of breast reduction specimens. Aesthet Plast Surg. 2002;26:203-205.
9. Khurana KK, Loosmann A, Numann PJ, Khan SA. Prophylactic mastectomy: Pathologic findings in high-risk patients. Arch Pathol Lab Med. 2000;124:378-381.
10. Tang CL, Brown MH, Levine R, Sloan M, Chong N, Holowaty E. A follow-up study of 105 women with breast cancer following reduction mammaplasty. Plast Reconstr Surg. 1999; 103:1687-1690.
11. Tang CL, Brown MH, Levine R, Sloan M, Chong N, Holowaty E. Breast cancer found at the time of breast reduction. Plast Reconstr Surg. 1999;103:1682-1686.
12. White RR 4th. Incidence of breast carcinoma in patients having reduction mammaplasty. Plast Reconstr Surg. 1998; 102:1774-1775.
13. Pitanguy I, Torres E, Salgado F, Pires Viana GA. Breast pathology and reduction mammaplasty. Plast Reconstr Surg. 2005;115:729-734; discussion 735.
14. Gottlieb JR, McKinney P, Walkinshaw MD, Sperling RL. Occult breast carcinoma in patients undergoing reduction mammaplasty. Aesthet Plast Surg. 1989;13:279-283.
15. Dinner MI, Artz JS. Carcinoma of the breast occurring in routine reduction mammaplasty. Plast Reconstr Surg. 1989; 83:1042-1044.
16. Springer HA. Reduction mammaplasty with discovery of occult breast carcinoma in twins: Case reports. Plast Reconstr Surg. 1978;62:122-124.
17. Karabela-Bouropoulou V, Liapi-Avgeri G, Iliopoulou E, Agnantis NJ. Histological findings in breast tissue specimens from reduction mammoplasties. Pathol Res Pract. 1994;190:792-798.
18. van der Torre PM, Butzelaar RM. Breast cancer and reduction mammoplasty: The role of routine pre-operative mammography. Eur J Surg Oncol. 1997;23:341-342.
19. Ozmen S, Yavuzer R, Latifoglu O, Atabay K. Coincidental breast carcinoma detection in reduction mammaplasty. Plast Reconstr Surg. 2000;106:1219-1220.
20. Brown MH, Weinberg M, Chong N, Levine R, Holowaty E. A cohort study of breast cancer risk in breast reduction patients. Plast Reconstr Surg. 1999;103:1674-1681. (Pubitemid 29206870)
21. Boice JD Jr, Friis S, McLaughlin JK, et al. Cancer following breast reduction surgery in Denmark. Cancer Causes Control 1997;8:253-258. (Pubitemid 27170381)
22. Baasch M, Nielsen SF, Engholm G, Lund K. Breast cancer incidence subsequent to surgical reduction of the female breast. Br J Cancer 1996;73:961-963.
23. Clugston PA, Son-Hing QR, MacFarlane JK. Detecting breast cancer after reduction mammaplasty. Can J Surg. 1991;34: 37-40.
24. Kukora JS, Goldhahn RT Jr, Buinewicz BR. Suspicious findings in reduction mammaplasty specimens: Review of 182 consecutive patients. Ann Plast Surg. 2004;52:126-130.
25. Rudolph R, Niedbala AR. Surgical management of patients with invasive carcinoma discovered at reduction mammoplasty. Am Surg. 2003;69:1003-1005.
26. Smith RA, Mettlin CJ, Davis KJ, Eyre H. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin. 2000;50:34-49.
27. Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005; 353:229-237.
28. Butler CE, Hunt KK, Singletary SE. Management of breast carcinoma identified intraoperatively during reduction mammaplasty. Ann Plast Surg. 2003;50:193-197.
29. Keleher AJ, Langstein HN, Ames FC, et al. Breast cancer in reduction mammaplasty specimens: Case reports and guidelines. Breast J. 2003;9:120-125.
30. Kuhl CK, Schrading S, Bieling HB, et al. MRI for diagnosis of pure ductal carcinoma in situ: A prospective observational study. Lancet 2007;370:485-492.
31. Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007;356:1295-1303. (Pubitemid 46513295)
32. Bondeson L, Linell F, Ringberg A. Breast reductions: What to do with all the tissue specimens? Histopathology 1985;9:281-285.